Anaptys Announces Participation in November and December Investor Conferences

a week ago

SAN DIEGO, Nov. 05, 2024 ( GLOBE NEWSWIRE ) -- AnaptysBio, Inc. ( Nasdaq: ANAB ) , a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its ...

Ticker	Sentiment	Impact
ANAB	Neutral	25 %